SCHEMBL6205167

SCHEMBL6205167

COC(O)Cc1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
IDO1 P14902 3/20 0.42
PNMT P11086 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
TAAR1 Q96RJ0 4/20 0.40
PKM P14618 1/20 0.40
LMNA P02545 1/20 0.40
NPC1 O15118 2/20 0.40
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 1/20 0.39
FABP4 P15090 1/20 0.39
FABP5 Q01469 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6202922 0.85 PNMT (0.47) IDO1PNMTSLC6A2SLC6A4SLC6A3
SCHEMBL6204367 0.78 AKR1B1 (0.39) SLC6A2SLC6A4SLC6A3TAAR1ALDH1A1
SCHEMBL6205188 0.78 LMNA (0.43) PPARGPPARASLC6A2SLC6A4SLC6A3
SCHEMBL6204800 0.78 ALOX15 (0.38) IDO1SLC6A2SLC6A4LMNAALDH1A1
SCHEMBL14520626 0.78 SLC6A2 (0.50) PPARGPPARAIDO1PNMTSLC6A2
SCHEMBL29679143 0.78 SLC6A2 (0.50) PPARGPPARAIDO1PNMTSLC6A2
SCHEMBL16534760 0.78 SLC6A2 (0.50) PPARGPPARAIDO1PNMTSLC6A2
SCHEMBL2423546 0.78 SLC6A2 (0.50) PPARGPPARAIDO1PNMTSLC6A2
SCHEMBL4298644 0.77 IDO1 (0.50) PPARGPPARAIDO1PNMTSLC6A2
SCHEMBL9480324 0.77 IDO1 (0.50) PPARGPPARAIDO1PNMTSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed